India vaccine Volunteers infection India

Covid decline may slow vaccine efficacy testing

Reading now: 940
www.livemint.com

covid-19 cases may handicap vaccine developers that are likely to start testing the effectiveness of their shots and potentially delay their approvals in India, where the first phase of the world’s largest immunization programme is set to start next week.Testing the effectiveness of vaccines, which is established in phase 3 of clinical trials, requires volunteers who have been infected by the coronavirus.Also Read | The curious case of the glowing beaches“Unless they do the trial in, say, Kerala, where daily cases are still high, it will take a lot of time for some of the participants across the placebo and vaccine arm (of the trial) to be infected.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA